Search

everythinglearnresearchcommunity

for

Search:↓

Patients in Australia underwent costly, unproven stem cell treatments due to weak regulations and aggressive marketing.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

Siblings with signs of virilization should be tested for non-classical congenital adrenal hyperplasia, which does not affect adult height but may impact fertility and well-being if untreated.

A man with rare skin changes on his fingers was diagnosed with multiple myeloma-linked amyloidosis.

Conditioned media from mesenchymal stem cells show promise for tissue repair and disease treatment, but more research is needed on their safety and effectiveness.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

Some women with excess hair growth have a hormone condition that can't be diagnosed by blood or urine tests alone.

The new ddPCR method reliably detects unwanted viruses in CAR-T cell products, ensuring their safety for patients.

Androgenetic alopecia is less common in Chilean Mapuche than Caucasians, but more common than Asians, with racial differences in prevalence and types.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Early diagnosis and treatment of achalasia and hyperthyroidism improve patient outcomes.

A girl with severe hair loss saw hair regrowth after using cannabis.

A young woman with late-stage Vogt-Koyanagi-Harada disease was successfully treated at a hospital.

New treatments for hair growth and psoriasis may be possible, and gene differences could affect baldness and the severity of skin conditions.

R-spondin2 may help treat hair loss, gene differences could explain baldness, a peptide's regulation is linked to psoriasis, B-defensin gene copies may affect a skin condition's risk and severity, and potential markers and targets for alopecia areata were identified.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

The secretions of mesenchymal stem cells could be used for healing without using the cells themselves.

Changing how mesenchymal stromal cells are grown can improve their healing abilities.

The document concludes that the fast-growing direct-to-consumer genetic testing market lacks sufficient regulation, posing risks to consumers due to questionable test quality and accuracy.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Regulatory T-cells are important for healing and regenerating tissues in various organs by controlling immune responses and aiding stem cells.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

Skin aging is due to impaired stem cell mobilization or fewer responsive stem cells.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.